Zebra Technologies reports strong Q3 results, but margins decline and guidance raises concerns about execution and the company's shift to software and services.
Tessa Thompson stars in Nia DaCosta's bold reimagining of Ibsen's 'Hedda Gabler' set in 1950s England.
Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.
Zebra Technologies reports strong Q3 results, but margins decline and guidance raises concerns about execution and the company's shift to software and services.
Tessa Thompson stars in Nia DaCosta's bold reimagining of Ibsen's 'Hedda Gabler' set in 1950s England.
Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.